ALNYLAM PHARMACEUTICALS INC COM USD0.01 financial statements, including revenue, expenses, profit, and loss

The total revenue of 0HD2 for the last quarter is 500.92 M USD, and it's 24.08% lower compared to the previous quarter. The net income of Q3 24 is -111.57 M USD.